Breakthrough drug works against all the main types of primary bone cancer
The drug, developed by researchers at the U.K.’s University of East Anglia, increases survival rates by 50% without the need for surgery or chemotherapy.
The drug, developed by researchers at the U.K.’s University of East Anglia, increases survival rates by 50% without the need for surgery or chemotherapy.
A British girl born with a rare and deadly genetic condition is expected to live a long and normal life after becoming the world’s first person to be cured with the help of a revolutionary gene therapy.
The new construction technique produces wind turbine towers 10 times faster while using up to 80% less manpower. Ultimately, this makes wind turbines much more affordable and cost-effective.
University of Adelaide researchers claim to have made clean hydrogen fuel from seawater without pre-treatment. Their findings could eventually provide cheaper green energy production from a near-limitless source to coastal areas.
Fungal infections cause more than 1.5 million deaths annually and cost billions. A new vaccine from the University of Georgia could be the first clinically approved immunization to protect against them.
The iron and steel industry is a major cause of greenhouse gasses, accounting for 9% of global emissions.
For decades researchers have been trying to develop a vaccine for the deadly respiratory disease. It looks like 2023 will be the landmark year where not only one, but possibly three different vaccines are approved.
Pilot programs are ongoing in Missouri, Pennsylvania, Virginia, California, and Hawai’i are already seeing promising results.
The Nature Conservancy announced it will work with partners to buy a piece of Barbados’ national debt and refinance it to facilitate this goal.
By creating a hairpin-shaped pair of DNA molecules, the researchers expose cancer to the immune system’s targeting procedure, and thus stop and even reverse cancer in mice.